Bispecific antibodies for cancer market size to grow by USD 40072 million between 2022 and 2027 Growth driven by the increasing prevalence of cancer Technavio
NEW YORK, April 3, 2023 /PRNewswire/ — The bispecific antibodies for cancer market size is forecasted to increase by USD 400.72 million from 2022 to 2027, at a CAGR of 8.82%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing prevalence of cancer, the advantages of bispecific antibodies over monoclonal antibodies, and a strong pipeline. Charts & data tables about market and segment sizes for a historic period (2017-2021) and forecast period (2023-2027) have been covered in this report. Download the Sample Report Vendor Analysis The global bispecific antibodies for…
